GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (CHIX:LLYz) » Definitions » Cyclically Adjusted Book per Share

Eli Lilly and Co (CHIX:LLYZ) Cyclically Adjusted Book per Share : CHF10.39 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Eli Lilly and Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Eli Lilly and Co's adjusted book value per share for the three months ended in Mar. 2024 was CHF11.979. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is CHF10.39 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Eli Lilly and Co's average Cyclically Adjusted Book Growth Rate was -2.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -1.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Eli Lilly and Co was 8.80% per year. The lowest was -2.00% per year. And the median was 4.40% per year.

As of today (2024-05-23), Eli Lilly and Co's current stock price is CHF710.00. Eli Lilly and Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was CHF10.39. Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is 68.33.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 64.61. The lowest was 4.09. And the median was 8.27.


Eli Lilly and Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Eli Lilly and Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Cyclically Adjusted Book per Share Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.30 9.17 10.17 11.73 11.50

Eli Lilly and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.83 10.56 12.04 11.50 10.39

Competitive Comparison of Eli Lilly and Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Cyclically Adjusted PB Ratio falls into.



Eli Lilly and Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.979/131.7762*131.7762
=11.979

Current CPI (Mar. 2024) = 131.7762.

Eli Lilly and Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 14.418 100.560 18.894
201409 14.869 100.428 19.510
201412 13.500 99.070 17.957
201503 13.173 99.621 17.425
201506 12.335 100.684 16.144
201509 13.359 100.392 17.535
201512 13.119 99.792 17.324
201603 13.341 100.470 17.498
201606 12.856 101.688 16.660
201609 13.743 101.861 17.779
201612 12.971 101.863 16.780
201703 12.735 102.862 16.315
201706 12.399 103.349 15.809
201709 13.016 104.136 16.471
201712 10.401 104.011 13.177
201803 12.603 105.290 15.773
201806 10.652 106.317 13.203
201809 11.863 106.507 14.678
201812 9.223 105.998 11.466
201903 2.556 107.251 3.140
201906 2.844 108.070 3.468
201909 3.490 108.329 4.245
201912 2.675 108.420 3.251
202003 3.086 108.902 3.734
202006 4.071 108.767 4.932
202009 4.617 109.815 5.540
202012 5.239 109.897 6.282
202103 6.685 111.754 7.883
202106 6.116 114.631 7.031
202109 7.483 115.734 8.520
202112 8.672 117.630 9.715
202203 9.123 121.301 9.911
202206 8.725 125.017 9.197
202209 10.315 125.227 10.855
202212 10.442 125.222 10.989
202303 10.910 127.348 11.289
202306 10.494 128.729 10.742
202309 10.633 129.860 10.790
202312 9.812 129.419 9.991
202403 11.979 131.776 11.979

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Eli Lilly and Co  (CHIX:LLYz) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=710.00/10.39
=68.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 64.61. The lowest was 4.09. And the median was 8.27.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Eli Lilly and Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co (CHIX:LLYZ) Business Description

Industry
Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Eli Lilly and Co (CHIX:LLYZ) Headlines

No Headlines